U.K. under pressure to reimburse Novartis' Bexsero; Hepatitis B vaccine uptake in China drops;

> The U.K. health secretary is under pressure to add Novartis' ($NVS) Bexsero to the immunization program. Article

> Fears sparked by infant deaths drove a 30% drop in hepatitis B vaccinations in China in December. News

> Australian physicians have warned vaccination rates in some areas have fallen to worrying levels. Piece

> ILiAD Biotechnologies has formed a collaborative alliance to develop live attenuated Bordetella pertussis vaccine technology. Item

> As many as 70 Pakistani health workers have refused to take part in a polio vaccination drive because of security concerns. Post

> Bend Research is to present details of its attempt to create highly stable flu vaccines. Release

> PaxVax has presented interim data from a Phase III trial of its cholera vaccine candidate. News

> Galena Biopharma ($GALE) has partnered with Dr. Reddy's to commercialize its cancer vaccine candidate in India. Article

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.